Forma Therapeutics Holdings (FMTX) Tops Q1 EPS by 12c

Forma Therapeutics Holdings (NASDAQ: FMTX) reported Q1 EPS of ($0.93), $0.12 better than the analyst estimate of ($1.05).

For earnings history and earnings-related data on Forma Therapeutics Holdings (FMTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M